English | Español
Jamie Barrand | Dec 27, 2015

Researchers unveil findings of acute lymphoblastic leukemia therapy trials
Jamie Barrand | Dec 27, 2015

New diabetes therapy receives final FDA approval
Jamie Barrand | Dec 27, 2015

AstraZeneca acquires majority stake in Acerta Pharma
Jamie Barrand | Dec 24, 2015

AHA names two injectable PCSK9 inhibitors among 2015's top research advances
Jamie Barrand | Dec 24, 2015

Merck, Pfizer launch phase III trial of ovarian cancer therapy
Jamie Barrand | Dec 24, 2015

New study links GABA activity to severity of autism symptoms
Jamie Barrand | Dec 24, 2015

AstraZeneca releases preliminary results from lung cancer drug's clinical trial
Jamie Barrand | Dec 24, 2015

FTA funds National Aging and Disability Transportation Center, improves accessibility

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access